VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
VanEck Biotech ETF · Issued by VanEck
| AMGN | Amgen Inc | 15.66% |
| GILD | Gilead Sciences Inc | 12.68% |
| VRTX | Vertex Pharmaceuticals Inc | 8.54% |
| REGN | Regeneron Pharmaceuticals Inc | 6.80% |
| MRNA | Moderna Inc | 5.70% |
| NTRA | Natera Inc | 5.08% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 5.03% |
| IQV | IQVIA Holdings Inc | 5.02% |
| ARGX | argenx SE ADR | 4.72% |
| ILMN | Illumina Inc | 3.34% |
No recent news for BBH. The ingest cron pulls every 15 minutes during market hours.